In keeping with a different AML etiology (eg. mutations in CEBPA, NPM1), the clinicopathologic features of the DDX41-s AMLs were heterogeneous and differed from what was seen in DDX41-m AMLs. Here, CEBPA is linked to acute myeloid leukemia.